How can you manage your company through the recession and position yourself for growth? After interviewing thousands of life sciences executives, we identified some overarching themes. From managing risks to improving capital allocation, we reveal the lessons that could mean the difference between surviving and thriving in the new economic environment.
Beyond borders: Global biotechnology report 2009
A deep funding drought. Depressed valuations. Demanding regulators and payors. These are challenging times. But are they unprecedented? Ernst & Young’s 23rd annual biotechnology report reveals how firms are responding with business strategies, new funding sources and creative deals. It also provides historical context, comprehensive data and insightful analysis to show how the business of biotech is going beyond business as usual, and what it means for you.
Biotechnology Pioneer takes out Ernst & Young World Entrepreneur Of The Year 2008
/$FILE/14L00119.jpg)